futurerobo34
Posted - 9 hours ago
$ROIV disappointed… stock should be well above $20.
SirSloth
Posted - 1 day ago
$ROIV 🤷🏻♂️
TimingTimingTiming
Posted - 1 day ago
$ROIV Will this go to the moon under Trump?
DocPharm
Posted - 3 days ago
$PFE $RHHBY $ROIV $ABUS Elections
Rate reductions
Earnings Calls
Conferences,
Oh, my
DonCorleone77
Posted - 3 days ago
$ROIV $OGN Organon completes acquisition of Dermavant Organon (OGN) announced completion of its acquisition of Dermavant Sciences from Roivant (ROIV). Dermavant is a company dedicated to developing and commercializing innovative therapeutic solutions in immuno-dermatology. VTAMA cream, 1%, is a novel nonbiologic, non-steroidal topical therapy approved by the U.S. Food and Drug Administration for treatment of mild, moderate, and severe plaque psoriasis in adults with no safety label warnings or precautions and without restrictions on location and duration of use or body surface area. The FDA is reviewing a supplemental New Drug Application for VTAMA cream as a potential treatment for atopic dermatitis in adults and children two years of age and older, with Prescription Drug User Fee Act action expected in the fourth quarter of calendar year 2024.
30DeltaSpy
Posted - 4 days ago
$ROIV im buying this when the market opens tomorrow
DocPharm
Posted - 6 days ago
$ABUS $ROIV always trade around a core position and build it out if you find a gem…
Sell the highest shares when it spikes & if the opportunity presents, buy them back… In the end you end up with a lower avg & more shares ABUS , I started at 3.87 avg 4+ years ago. Now I’m sub 2.50 ☺️ with 8-10x the shares depending on the day
countingguy2006
Posted - 6 days ago
$ABUS $ABUS $ROIV Adjust your positions accordingly. If you are holding these stocks for the long term, it's ok but take some profit on positions when it presents itself. Buy and hold long term without profit taking when considering inflation and the capital costs of money from letting it stagnate in reality is a loss and/or devaluing in your positions and brokerage accounts!
T7Boeing
Posted - 6 days ago
$ABUS $CRSP $EDIT $ROIV $SGMO — SANGFRAUDMO — No thanks. Zinc fingers are outdated dangerous tech. Little weaklings pumping a penny stock nearing bankruptcy amuse me
brs555
Posted - 1 week ago
$ABUS There are a lot of well informed people here especially on the Arbutus/Roivant ST board. I have respectful positions in $SGMO $ABUS $ROIV. $ROIV owns 84% of Genevant a private company. $EDIT announced yesterday they are in collaboration with Genevant to develop novel gene editing therapeutics using the $CRSP platform. My question is WHY? Sangamo has a game changing editing system. $SGMO is valued at $330m. Crispr $4B. $ROIV should take a controlling stake in $SGMO. Fabry is Icing on the cake. Forget that deal with $EDIT. https://www.sangamo.com/science/technology-platforms/zinc-finger-platform/
DocPharm
Posted - 1 week ago
$MRNA almost time to build a position here…
Below my target but still have a lot to address with $roiv & $abus
Without delivery, there is no pipeline 👀👀
SpaceCityKid
Posted - 1 week ago
$ROIV Trying hard to turn up off the bottom of channel. Next tgt 12.32
brs555
Posted - 1 week ago
@thebenchwarmers Matts repeatedly said that's not their wheelhouse. IE the $EDIT deal is. Small hits..singles doubles...That's why $ROIV doesn't go anywhere....HELL it doesn't even go anywhere when they hit a home run for over $5 Billion. I've said it before. Roivant is a holding company. Not a biotech. Not going anywhere unless the cash price for their shares increases... IE sold VTAMA recently...
brs555
Posted - 1 week ago
$ROIV $ABUS Roivant $1M share trade after hours
mbentinck
Posted - 1 week ago
$IPA $ROIV $RXRX https://seekingalpha.com/article/4728318-roivant-sciences-good-value-but-near-term-catalysts-could-bring-volatility
"What these partnerships and subsidiaries make very clear is that Techbio is hot in big pharma land and that more and more partnerships are being forged in recent years. Investing opportunities in Techbio land are plenty.
In the more aggressive part of my portfolio, my personal favorite here is ImmunoPrecise Antibodies Ltd. (IPA), a company which has an EV/revenue multiple of only 1.37, has several partnerable assets in its subsidiary TALEM Therapeutics, and has an impressive AI-based engine called BioStrand that has only recently been commercialized.”
insiderbuyingselling
Posted - 1 week ago
$ROIV new insider selling: 100000 shares. http://insiderbuyingselling.com/?t=ROIV
DENARIUS_CENTURION
Posted - 1 week ago
$ROIV $IPA $RXRX
Victor_Lustig
Posted - 1 week ago
$IPA $RXRX $ROIV https://seekingalpha.com/article/4728318-roivant-sciences-good-value-but-near-term-catalysts-could-bring-volatility "In the more aggressive part of my portfolio, my personal favorite here is ImmunoPrecise Antibodies Ltd. (IPA), a company which has an EV/revenue multiple of only 1.37, has several partnerable assets in its subsidiary TALEM Therapeutics, and has an impressive AI-based engine called BioStrand that has only recently been commercialized."
DocPharm
Posted - 1 week ago
$ROIV ⏱️ ⏱️ ⏱️ $PFE $MRNA $ABUS Summary:
Roivant's high valuation stems from its strong cash position, promising drug pipeline, Techbio assets, and strategic partnerships, making it a compelling buy.
Recent sales of Telavant and Dermavant have bolstered Roivant's cash reserves.
Key potential catalysts include Immunovant’s batoclimab in Phase 3 trials and namilumab in a Phase 2 trial, though drug candidate performance remains a critical risk factor.
Litigation against Moderna and Pfizer, coupled with Techbio advancements, could drive future valuation.
DocPharm
Posted - 1 week ago
$ABUS $gsk
But let’s not forget the pioneers $ABUS $ROIV $genevant
If the damages of GSK could be so severe, I can’t imagine the ones already pending with the aforementioned
Tparn
Posted - 1 week ago
$ROIV …mid $11’s = total buy zone…
DocPharm
Posted - 1 week ago
$XBI can only suppress for so long…too much money flowing in Adding on dips $ROIV $PFE $ABUS $RHHBY
UncleStock
Posted - 1 week ago
$INBX $ICG $IH $ROIV suggested for Greenblatt - value screen: https://zpr.io/UTuPZph7JaaR
invisio
Posted - 2 weeks ago
@furzah @EdDwg @thebenchwarmers if and when this is proven right $ROIV could buy out $BRNS instead of acquiring $ABUS , which they already own and control.. advantage is they know the study results before any other interested party.. the chart of $BRNS looks like it's going the trash way with a current mcap of just $45m , maybe they do know that they are endangered to run out of money sooner or later and not being able to finance further studies without any solvent partner.. ROIV could fill that gap!
RonIsWrong
Posted - 2 weeks ago
$ROIV knocking on that $12 door, again.
DocPharm
Posted - 2 weeks ago
with vanguard being a big holder of $abus ; I’m sure the new BoD at $PFE is highlighting a big risk they haven’t addressed with their somewhat pal $ROIV just yet LNP; Marksman 18 Dec $abus /$roiv /$pfe
CDMO
Posted - 2 weeks ago
$ROIV looking good
swizzlesticks
Posted - 2 weeks ago
$ROIV Sad part China has lost $ 20 trillion in the largest asset in the world with there reality
swizzlesticks
Posted - 2 weeks ago
$ROIV GSK now in lawsuit with MRNA
Joe_Mama
Posted - 2 weeks ago
$ROIV In the channel. Can we break into the upper half